Collegium Pharmaceutical, Inc. COLL Repayments Of Notes Payable
Repayments Of Notes Payable at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfNotesPayable.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s repayments of notes payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s repayments of notes payable?
- Collegium Pharmaceutical, Inc. (COLL) reported repayments of notes payable of $7.25M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s repayments of notes payable changed year-over-year?
- Collegium Pharmaceutical, Inc.'s repayments of notes payable decreased by 55.1% year-over-year, from $16.15M to $7.25M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s repayments of notes payable?
- Over 3 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s repayments of notes payable has grown at a 133.4% compound annual growth rate (CAGR), from $50M to $635.56M.